Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin. 2002

Jolanda M Smit, and Barry-Lee Waarts, and Koji Kimata, and William B Klimstra, and Robert Bittman, and Jan Wilschut
Molecular Virology Section, Department of Medical Microbiology, University of Groningen, Ant. Deusinglaan 1, 9713 AV Groningen, The Netherlands.

Passage of Sindbis virus (SIN) in BHK-21 cells has been shown to select for virus mutants with high affinity for the glycosaminoglycan heparan sulfate (HS). Three loci in the viral spike protein E2 (E2:1, E2:70, and E2:114) have been identified that mutate during adaptation and independently confer on the virus the ability to bind to cell surface HS (W. B. Klimstra, K. D. Ryman, and R. E. Johnston, J. Virol. 72:7357-7366, 1998). In this study, we used HS-adapted SIN mutants to evaluate a new model system involving target liposomes containing lipid-conjugated heparin (HepPE) as an HS receptor analog for the virus. HS-adapted SIN, but not nonadapted wild-type SIN TR339, interacted efficiently with HepPE-containing liposomes at neutral pH. Binding was competitively inhibited by soluble heparin. Despite the efficient binding of HS-adapted SIN to HepPE-containing liposomes at neutral pH, there was no fusion under these conditions. Fusion did occur, however, at low pH, consistent with cellular entry of the virus via acidic endosomes. At low pH, wild-type or HS-adapted SIN underwent fusion with liposomes with or without HepPE with similar kinetics, suggesting that interaction with the HS receptor analog at neutral pH has little influence on subsequent fusion of SIN at low pH. Finally, Semliki Forest virus (SFV), passaged frequently on BHK-21 cells, also interacted efficiently with HepPE-containing liposomes, indicating that SFV, like other alphaviruses, readily adapts to cell surface HS. In conclusion, the liposomal model system presented in this paper may serve as a novel tool for the study of receptor interactions and membrane fusion properties of HS-interacting enveloped viruses.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008561 Membrane Fusion The adherence and merging of cell membranes, intracellular membranes, or artificial membranes to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes. Fusion, Membrane,Fusions, Membrane,Membrane Fusions
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D010714 Phosphatidylethanolamines Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids. Cephalin,Cephalins,Ethanolamine Phosphoglyceride,Ethanolamine Phosphoglycerides,Ethanolamineglycerophospholipids,Phosphoglyceride, Ethanolamine,Phosphoglycerides, Ethanolamine
D011721 Pyrenes A group of condensed ring hydrocarbons.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006497 Heparitin Sulfate A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS. Heparan Sulfate,Sulfate, Heparan,Sulfate, Heparitin

Related Publications

Jolanda M Smit, and Barry-Lee Waarts, and Koji Kimata, and William B Klimstra, and Robert Bittman, and Jan Wilschut
June 1979, The Journal of general virology,
Jolanda M Smit, and Barry-Lee Waarts, and Koji Kimata, and William B Klimstra, and Robert Bittman, and Jan Wilschut
October 2007, Current protocols in neuroscience,
Jolanda M Smit, and Barry-Lee Waarts, and Koji Kimata, and William B Klimstra, and Robert Bittman, and Jan Wilschut
October 2011, Current protocols in neuroscience,
Jolanda M Smit, and Barry-Lee Waarts, and Koji Kimata, and William B Klimstra, and Robert Bittman, and Jan Wilschut
June 1974, Journal of virology,
Jolanda M Smit, and Barry-Lee Waarts, and Koji Kimata, and William B Klimstra, and Robert Bittman, and Jan Wilschut
August 1981, Virology,
Jolanda M Smit, and Barry-Lee Waarts, and Koji Kimata, and William B Klimstra, and Robert Bittman, and Jan Wilschut
July 2010, Matrix biology : journal of the International Society for Matrix Biology,
Jolanda M Smit, and Barry-Lee Waarts, and Koji Kimata, and William B Klimstra, and Robert Bittman, and Jan Wilschut
August 2002, Current protocols in human genetics,
Jolanda M Smit, and Barry-Lee Waarts, and Koji Kimata, and William B Klimstra, and Robert Bittman, and Jan Wilschut
April 2007, Journal of virology,
Jolanda M Smit, and Barry-Lee Waarts, and Koji Kimata, and William B Klimstra, and Robert Bittman, and Jan Wilschut
January 1997, Journal of virology,
Jolanda M Smit, and Barry-Lee Waarts, and Koji Kimata, and William B Klimstra, and Robert Bittman, and Jan Wilschut
October 1979, Journal of virology,
Copied contents to your clipboard!